Biotech, pharmaceutical companies bet on promising class of cancer drugs to fuel growth
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO – Established but a promising group of cancer drugs was a hot market in 2023, and more companies could look to treatments to fuel growth in the coming year. That … Read more